Pharmafile Logo
Pharmafocus logo
Advanced Search
vaccination-1215279_960_720

Russia’s Sputnik COVID-19 vaccine has 91.4% efficacy after 28 days, new interim data show

November 24, 2020
Manufacturing and Production, Research and Development COVID-19, Sputnik V, Vaccine

The National Research Center for Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF) have released a statement saying …

News
fda_white_oak_building_web_0

FDA approves Oxlumo for treating primary hyperoxaluria type 1

November 24, 2020
Manufacturing and Production

The FDA has approved Oxlumo (lumasiran) as the first treatment for primary hyperoxaluria type 1 (PH1).  This rare genetic condition …

News

Sanofi’s invasive meningococcal disease vaccine approved for EU use in four serotypes

November 23, 2020
Research and Development, Sales and Marketing

Sanofi’s MenQuadfi combination vaccine has secured approval from the European Commission for the prevention of invasive meningococcal disease caused by …

News
dado_ruvic-illustration-reuters

Interim analysis for AstraZeneca’s COVID-19 vaccine finds 70% average efficacy

November 23, 2020
Research and Development, Sales and Marketing AstraZeneca, COVID-19, Vaccine

Hot on the heels of Moderna and Pfizer/BioNTech who both have released very promising data for their mRNA COVID-19 vaccine …

News
1200px-vaccine_image_1_1

Americans could get coronavirus vaccine by December, according to leader of Operation Warp Speed

November 23, 2020
Sales and Marketing

Certain Americans could receive a coronavirus vaccine as early as next month, according to Dr Moncef Slaoui, Chief Scientific Adviser …

News
fda_21_4_1_0

FDA grants Emergency Use Authorization for Regeneron’s antibody treatment

November 23, 2020
Sales and Marketing

The FDA has granted Emergency Use Authorization for Regeneron’s coronavirus antibody treatment which was used to treat President Donald Trump …

News
jnjioffice_1

Johnson & Johnson set to pay $120 million in New York baby powder case

November 23, 2020
Sales and Marketing

A New York judge has ordered Johnson & Johnson to pay $120 million to a woman and her husband after …

News
1200px-logo_of_the_world_health_organization

World Health Organization does not recommend using remdesivir to treat COVID-19

November 20, 2020
Medical Communications

The World Health Organization does not recommend using Gilead’s antiviral drug remdesivir to treat hospitalised COVID-19 patients, no matter how …

News

Eli Lilly and Ypsome partner to advance automated insulin delivery system

November 20, 2020
Medical Communications

Eli Lilly has entered into a global non-exclusive agreement with Ypsomed for the advancement of an automated insulin delivery system …

News
fdaoutsideweb

Pfizer and BioNTech to request FDA Emergency Use Authorisation for their COVID-19 vaccine today

November 20, 2020
Medical Communications, Sales and Marketing BioNTech, COVID-19, Pfizer, Vaccine

Pfizer and BioNTech are reportedly gearing up to submit a formal application for Emergency Use Authorisation to the FDA later …

News
influenza

First recombinant influenza vaccine approved in the European Union

November 20, 2020
Medical Communications, Sales and Marketing Europe, influenza, pharma

The European Commission (EC) has just approved its first recombinant influenza vaccine for the European Union, awarding marketing authorisation to …

News
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

November 20, 2020
Medical Communications

The top ten news stories this week centre around coronavirus vaccine clinical trial results, as Pfizer and BioNTech have backed …

News
gilead-sciences

Gilead’s lenacapavir meets primary goal in heavily treated and multidrug resistant HIV-1

November 19, 2020
Research and Development Gilead, HIV, pharma

Gilead has pulled back the curtain on promising new data for its long-acting HIV-1 capsid inhibitor lenacapavir for heavily treated …

News

OPEN Health reveals new CEO appointment

November 19, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Open Health

Rob Barker has been named as the new Chief Executive Officer (CEO) at health communications and market access group OPEN …

News
download

First multiple sclerosis clinical trial for patients who can’t walk to begin recruitment

November 19, 2020
Business Services

The first clinical trial to focus on multiple sclerosis (MS) patients who can’t walk will begin enrolling patients next year.  …

News
flu_vaccination_grippe_5115654021_3

Five Chinese coronavirus vaccines in overseas clinical trials

November 19, 2020
Business Services

Five different coronavirus vaccines from China are being tested in Phase 3 trials around the world.  The countries conducting the …

News
1200px-flag_of_vietnam

Vietnam selected as Asian pilot country for UK’s new global healthcare partnership

November 19, 2020
Business Services

A new global healthcare partnership funded by the World Economic Forum (WEF), the London School of Economics and AstraZeneca has …

News
bristol_myers_squibb_moreton_wirral_-_img_0369

Bristol Myers Squibb completes $13.1 billion acquisition of MyoKardia

November 18, 2020
Research and Development

Bristol Myers Squibb has announced that its acquisition of MyoKardia has been completed, with the transaction worth a total of …

News
lilly_building_with_american_flag_web

NICE recommends Lilly’s Emgality for chronic and episodic migraine

November 18, 2020
Research and Development, Sales and Marketing Eli Lilly, NHS, NICE, UK

Eli Lilly’s Emgality (galcanezumab) is set to become an approved option for the prevention of episodic and chronic migraine on …

News
fda_21_4_1_0

FDA approves first at-home coronavirus self-testing kit

November 18, 2020
Research and Development

The FDA has issued an Emergency Use Authorization for the first coronavirus self-testing kit for use at home that produces …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026